$VUZI
Vuzix Corporation
XNAS
Why is VUZI down today? It is at $2.62 (-1.50%), and our scanner flagged it 52 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VUZI spikes, and full due diligence on VUZI — key stats, earnings, dilution and insider activity. Free.
Get free $VUZI alerts the moment volume spikes
Our scanner flagged $VUZI 52 times in the last 30 days. Create a free account to track $VUZI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.62
- Change today
- -1.50%
- Previous close
- $2.66
- 52-week range
- $1.97 – $5.62
- Market cap
- $221M
- Institutional own.
- 43.13%
- Total held
- 50.4%
- Tradeable float
- 41.9M 50% of shares · after 7% insiders + 43% institutions
- Avg daily volume
- 1.8M
- Exchange
- XNAS
- 5mthin
- 0.0x
- 15mthin
- 0.0x
- 1hthin
- 0.0x
- 1D
- 0.2x
Get free VUZI + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $VUZI down today?
Here is the latest on VUZI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VUZI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVuzix® Corporation (NASDAQ: VUZI),Reported ($000s except per share amounts)Reported the three months ended June 30, 2026, total revenues decreased by 14% to $1.1 million versus $1.3 million for the comparable periodReported in 2025. Product sales were $0.9 million versus $1.0 million, a decrease of 15%. Engineering services and OEM product sales were $0.2, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying3 buys, 0 sells last 3 months (4/4 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mackinnon Alasdair John Director | Acquired (grant/award) | +29K 0.03% of company | added 45% | 95K | n/a | Jul 15, 26 |
Whitten-Doolin Paula Beck Director | Acquired (grant/award) | +29K 0.03% of company | added 32% | 120K | n/a | Jul 15, 26 |
Harned Timothy Heydenreich Director | Acquired (grant/award) | +29K 0.03% of company | added 9.2% | 348K | n/a | Jul 15, 26 |
Whitten-Doolin Paula Beck Director | Sold (automatic/other) | -32K 0.04% of company | sold 26% | 91K | $150K at $4.68 | May 26, 26 |
Harned Timothy Heydenreich Director | Sold (automatic/other) | -10K 0.01% of company | sold 3.0% | 318K | $47K at $4.73 | May 21, 26 |
Parkinson Christopher Iain Officer | Sold (automatic/other) | -12K 0.01% of company | sold 8.2% | 131K | $31K at $2.69 | Mar 4, 26 |
Parkinson Christopher Iain Officer | Sold (automatic/other) | -9K 0.01% of company | sold 6.2% | 143K | $28K at $2.92 | Dec 22, 25 |
Parkinson Christopher Iain Officer | Acquired (grant/award) | +150K 0.2% of company | added 100% | 152K | n/a | Sep 29, 25 |
Mackinnon Alasdair John Director | Acquired (grant/award) | +65K 0.08% of company | n/a | 65K | n/a | Aug 5, 25 |
Harned Timothy Heydenreich Director | Acquired (grant/award) | +32K 0.04% of company | added 11% | 328K | n/a | Jul 1, 25 |
Kay Edward William Jr. Director | Acquired (grant/award) | +32K 0.04% of company | added 11% | 310K | n/a | Jul 1, 25 |
Whitten-Doolin Paula Beck Director | Acquired (grant/award) | +32K 0.04% of company | added 35% | 123K | n/a | Jul 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $VUZI runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 38,167,939 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $2.62/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$VUZI Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$VUZI Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



VUZI stock FAQ
Why is $VUZI down today?
Here is the latest on VUZI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VUZI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the VUZI stock price today?
VUZI last traded at $2.62, down 1.50% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live VUZI alerts?
The VUZI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VUZI 52 times in the last 30 days.
What exchange is VUZI on?
VUZI (Vuzix Corporation) trades on XNAS, with a market cap of about $221M.
Is VUZI good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VUZI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.